Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.

Reiberger, Thomas

Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver Apr 2013 - 561-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1478-3231

10.1111/liv.12101 doi


Administration, Oral
Adrenergic beta-Antagonists--administration & dosage
Animals
Benzopyrans--administration & dosage
Blood Flow Velocity--drug effects
Collateral Circulation--drug effects
Common Bile Duct--surgery
Dose-Response Relationship, Drug
Ethanolamines--administration & dosage
Glutathione--metabolism
Heart Rate--drug effects
Hypertension, Portal--etiology
Ligation
Liver--blood supply
Liver Circulation--drug effects
Liver Cirrhosis, Experimental--complications
Male
Mesenteric Artery, Superior--drug effects
Nebivolol
Nitric Oxide--metabolism
Oxidation-Reduction
Portal Pressure--drug effects
Rats
Rats, Sprague-Dawley
Signal Transduction--drug effects
Splanchnic Circulation--drug effects
Up-Regulation